Bildkälla: Stockfoto

Xspray Pharma Q4’21: According to Plan - Redeye

Redeye leaves its comment on Xspray following the announcement of today’s year-end report. Despite the encouraging news announced recently, Xspray shares trade near our Bear case, but for how long?

Redeye leaves its comment on Xspray following the announcement of today’s year-end report. Despite the encouraging news announced recently, Xspray shares trade near our Bear case, but for how long?
Börsvärldens nyhetsbrev
ANNONSER